Lv2
190 积分 2024-04-03 加入
Quality of Life Issues Following Breast Cancer Treatment
8小时前
求助中
Abstract P1-11-01: Trastuzumab deruxtecan vs treatment of physician’s choice in patients with HER2-low unresectable and/or metastatic breast cancer: Subgroup analyses from DESTINY-Breast04
8天前
已关闭
Abstract HER2-18: HER2-18 Determination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04
8天前
已关闭
Gastroesophageal Reflux Disease—Functional Dyspepsia Overlap: Do Birds of a Feather Flock Together?
18天前
已完结
Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin
21天前
已完结
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
23天前
已完结
Comparative efficacy and safety of eribulin versus paclitaxel in breast cancer: a systematic review and meta-analysis
23天前
已完结
Patient satisfaction with therapeutic education in oncology: Antecedents, consequences, and the moderating effect of perceived value
24天前
已完结
The high costs of anticancer therapies in the USA: challenges, opportunities and progress
29天前
已完结
Translation of Karnofsky Performance Status (KPS) for use in inpatient cancer rehabilitation
1个月前
已完结
皖公网安备34019202002308
